文献速递其他结缔组织病

多国系统性硬化症起始队列中的早期死亡

Early Mortality in a Multinational Systemic Sclerosis Inception Cohort.
PubMed 文献 · Arthritis Rheumatol · 2017-04-06

该多国起始队列纳入发病4年内的系统性硬化症(SSc)患者1070例,中位随访3.0年,死亡140例(13%),合并标准化死亡比(SMR)为4.06(95%CI 3.39-4.85),女性最多损失22.4年寿命、男性最多损失26.0年,弥漫型病8年死亡率为24.2%。62.1%的主要死因与SSc相关,早期死亡预测因素包括男性、发病年龄较大、弥漫型、肺动脉高压和肾危象。

要点

  • SSc起始队列早期死亡显著,合并SMR为4.06。
  • 弥漫型病8年死亡率24.2%,男性寿命损失最多26.0年。
  • 62.1%主要死因与SSc相关,男性、弥漫型等预测早期死亡。

核心结论

  • SSc早期死亡负担重,起始队列SMR为4.06,高于 prevalent 队列的3.39。

研究设计与样本

  • 多国起始队列纳入发病4年内SSc患者1070例,并与3218例 prevalent 队列比较。
  • 中位随访3.0年(四分位距1.0-5.1年),用标准化病例报告表判定单一主要死因。
  • 采用多变量Cox回归评估死亡预测因素。

主要发现

  • 起始队列140例死亡(13%),合并SMR为4.06(95%CI 3.39-4.85)。
  • 女性最多损失22.4年寿命,男性最多损失26.0年。
  • 弥漫型病8年死亡率为24.2%,62.1%主要死因与SSc相关。
  • 非SSc相关死因最常见为恶性肿瘤、脓毒症、脑血管病和缺血性心脏病。
  • 早期死亡预测因素包括男性、发病年龄较大、弥漫型、肺动脉高压和肾危象。

关键数值与推荐

  • 起始队列合并SMR为4.06(95%CI 3.39-4.85)。
  • prevalent 队列合并SMR为3.39(95%CI 3.06-3.71)。
  • 弥漫型病8年死亡率为24.2%。
  • 62.1%的主要死因为SSc相关。

临床怎么用

  • 对SSc早期患者应关注男性、发病年龄较大、弥漫型、肺动脉高压和肾危象等高危因素。
  • prevalent 队列可能低估SSc早期死亡,尤其男性和弥漫型患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine mortality and causes of death in a multinational inception cohort of subjects with systemic sclerosis (SSc). METHODS: We quantified mortality as standardized mortality ratio (SMR), years of life lost, and percentage mortality in the first decade of disease. The inception cohort comprised subjects recruited within 4 years of disease onset. For comparison, we used a prevalent cohort, which included all subjects irrespective of disease duration at recruitment. We determined a single primary cause of death (SSc related or non-SSc related) using a standardized case report form, and we evaluated predictors of mortality using multivariable Cox regression. RESULTS: In the inception cohort of 1,070 subjects, there were 140 deaths (13%) over a median follow-up of 3.0 years (interquartile range 1.0-5.1 years), with a pooled SMR of 4.06 (95% confidence interval [95% CI] 3.39-4.85), up to 22.4 years of life lost in women and up to 26.0 years of life lost in men, and mortality in the diffuse disease subtype of 24.2% at 8 years. In the prevalent cohort of 3,218 subjects, the pooled SMR was lower at 3.39 (95% CI 3.06-3.71). In the inception cohort, 62.1% of the primary causes of death were SSc related. Malignancy, sepsis, cerebrovascular disease, and ischemic heart disease were the most common non-SSc-related causes of death. Predictors of early mortality included male sex, older age at disease onset, diffuse disease subtype, pulmonary arterial hypertension, and renal crisis. CONCLUSION: Early mortality in SSc is substantial, and prevalent cohorts underestimate mortality in SSc by failing to capture early deaths, particularly in men and those with diffuse disease.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Hao Y, Hudson M, Baron M, et al. Early Mortality in a Multinational Systemic Sclerosis Inception Cohort. Arthritis Rheumatol. 2017. PMID: 28029745. doi:10.1002/art.40027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。